Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.

Torres A, Garau J, Arvis P, Carlet J, Choudhri S, Kureishi A, Le Berre MA, Lode H, Winter J, Read RC; MOTIV (MOxifloxacin Treatment IV) Study Group.

Clin Infect Dis. 2008 May 15;46(10):1499-509. doi: 10.1086/587519.

PMID:
18419482
2.

The emerging epidemiology of VRE in Canada: results of the CNISP Passive Reporting Network, 1994 to 1998.

Conly JM, Ofner-Agostini M, Paton S, Johnston L, Mulvey M, Kureishi A, Nicolle L, Matlow A; Canadian Hospital Epidemiology Commmittee; Canadian Nosocomial Infection Surveillance Program.

Can J Infect Dis. 2001 Nov;12(6):364-70.

3.

Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance.

Martin M, Quilici S, File T, Garau J, Kureishi A, Kubin M.

J Antimicrob Chemother. 2007 May;59(5):977-89. Epub 2007 Mar 29.

PMID:
17395688
4.

Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial.

Ross JD, Cronjé HS, Paszkowski T, Rakoczi I, Vildaite D, Kureishi A, Alefelder M, Arvis P, Reimnitz P; MAIDEN Study Group.

Sex Transm Infect. 2006 Dec;82(6):446-51. Epub 2006 May 24.

5.

Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.

Niederman MS, Anzueto A, Sethi S, Choudhri S, Kureishi A, Haverstock D, Perroncel R.

Respir Med. 2006 Oct;100(10):1781-90. Epub 2006 Mar 13.

6.

New strains of bacteria and exacerbations of COPD.

Kureishi A.

N Engl J Med. 2002 Dec 19;347(25):2077-9; author reply 2077-9; discussion 2077-9. No abstract available.

PMID:
12490693
7.

Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals.

Macphail GL, Taylor GD, Buchanan-Chell M, Ross C, Wilson S, Kureishi A.

Mycoses. 2002 Jun;45(5-6):141-5.

PMID:
12100528
8.

Vancomycin-resistant enterococci (VRE) in Canada - Results of the Canadian Nosocomial Infection Surveillance Program 1996 VRE point prevalence surveillance project.

Ofner-Agostini ME, Conly J, Paton S, Kureishi A, Nicolle L, Mulvey M, Johnson W, Johnston L; Canadian Hospital Epidemiology Committee.

Can J Infect Dis. 1997 Mar;8(2):73-8. No abstract available.

9.

Herpes simplex mastitis: Case report and review of the literature.

Brown H, Kneafsey P, Kureishi A.

Can J Infect Dis. 1996 May;7(3):209-12.

10.

Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment.

Laing FP, Ramotar K, Read RR, Alfieri N, Kureishi A, Henderson EA, Louie TJ.

J Clin Microbiol. 1995 Mar;33(3):513-8.

11.

Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori.

Moore RA, Beckthold B, Wong S, Kureishi A, Bryan LE.

Antimicrob Agents Chemother. 1995 Jan;39(1):107-11.

12.

Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.

Kureishi A, Diver JM, Beckthold B, Schollaardt T, Bryan LE.

Antimicrob Agents Chemother. 1994 Sep;38(9):1944-52.

14.

Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.

Chow AW, Jewesson PJ, Kureishi A, Phillips GL.

Eur J Haematol Suppl. 1993;54:18-24. Review.

PMID:
8365461
15.
16.

Rabies in China: recommendations for control.

Kureishi A, Xu LZ, Wu H, Stiver HG.

Bull World Health Organ. 1992;70(4):443-50. Review.

17.

Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.

Kureishi A, Jewesson PJ, Rubinger M, Cole CD, Reece DE, Phillips GL, Smith JA, Chow AW.

Antimicrob Agents Chemother. 1991 Nov;35(11):2246-52.

18.

Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patients.

Kureishi A, Jewesson PJ, Bartlett KH, Cole CD, Chow AW.

Antimicrob Agents Chemother. 1990 Sep;34(9):1642-7.

19.

Kinetics of intraventricular vancomycin in infections of cerebrospinal fluid shunts.

Reesor C, Chow AW, Kureishi A, Jewesson PJ.

J Infect Dis. 1988 Nov;158(5):1142-3. No abstract available.

PMID:
3183426
20.

The tender tooth. Dentoalveolar, pericoronal, and periodontal infections.

Kureishi A, Chow AW.

Infect Dis Clin North Am. 1988 Mar;2(1):163-82. Review.

PMID:
3074106

Supplemental Content

Loading ...
Support Center